EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nanomaterial-Enabled Electrochemical Biosensing Platforms for Circulating Tumor Cell Analysis

Xinggang Yang iD, Guonian Zhu, Zhe Wen, Hongxia Su, Xuping Sun iD, Weimin Li iD, Zhoufeng Wang

ACS Sensors · 05.11.2026

DOI: 10.1021/acssensors.6c02238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 05.11.2026. Verfasst von Xinggang Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network…. Die Arbeit nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) are valuable liquid biopsy markers for assessing tumor heterogeneity, monitoring minimal residual disease (MRD), and guiding personalized therapy. However, their rarity in blood and phenotypic changes during epithelial–mesenchymal transition (EMT) limit reliable detection. Electrochemical interfacial biosensors offer a promising solution due to their high sensitivity, miniaturization potential, and compatibility with microfluidics. This review summarizes recent advances in nanomaterial-enabled electrochemical CTC biosensing, focusing on interface engineering, signal transduction, and clinical translation. We highlight strategies such as multivalent recognition, engineered nanotopography, antifouling interfaces, and stimulus-responsive release that enhance CTC capture in whole blood. We also discuss nanozyme-based amplification, ratiometric calibration, and multiplexed electrochemical detection for phenotypic profiling beyond simple enumeration. Finally, we outline key translational requirements, including standardized benchmarking, clinical cohort validation, and artificial intelligence (AI)-assisted data analysis. Integrating nanostructured interfaces with multiplexed detection and standardized whole-blood validation may accelerate electrochemical CTC analysis toward routine, phenotype-aware liquid biopsy.

Schlagwörter

Stichwörter der Autor:innen

circulating tumor cellsclinical translationelectrochemical biosensinginterface engineeringliquid biopsynanomaterialsphenotypic profilingsignal amplification

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan610041, Chi…
  • Institute of Respiratory Health, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, Sichuan610041, China.
  • State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical…
  • West China School of Nursing, Sichuan University, Chengdu, Sichuan610041, China.
  • Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan610041, China.
  • College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan, Shandong250014, China.

ORCID-Profile: Xinggang Yang, Xuping Sun, Weimin Li

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • 1·3·5 Project of State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University
  • State Key Laboratory Special Fund

Zitieren

APA

Yang, X., Zhu, G., Wen, Z., Su, H., Sun, X., Li, W., & Wang, Z. (2026). Nanomaterial-Enabled Electrochemical Biosensing Platforms for Circulating Tumor Cell Analysis. ACS Sensors. https://doi.org/10.1021/acssensors.6c02238

Vancouver

Yang X, Zhu G, Wen Z, Su H, Sun X, Li W, et al. Nanomaterial-Enabled Electrochemical Biosensing Platforms for Circulating Tumor Cell Analysis. ACS Sensors. 2026. doi:10.1021/acssensors.6c02238

BibTeX
@article{Yang2026,
  author = {Yang, Xinggang and Zhu, Guonian and Wen, Zhe and Su, Hongxia and Sun, Xuping and Li, Weimin and Wang, Zhoufeng},
  title = {Nanomaterial-Enabled Electrochemical Biosensing Platforms for Circulating Tumor Cell Analysis},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.6c02238}
}
Kostenlos starten →